ArticleAllergy2025

Dupilumab Treatment Is Associated With Clinical Improvement and a Shift Toward a Health-Associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis.

Fabio S Ryser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.